---
figid: PMC6130939__zbc0371892730011
figtitle: GRK2 mediates TCR-induced transactivation of CXCR4 and TCR–CXCR4 complex
  formation required for PI3KG/PREX1 signaling and robust T cell cytokine secretion
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6130939
filename: zbc0371892730011.jpg
figlink: /pmc/articles/PMC6130939/figure/F11/
number: F11
caption: GRK2 mediates TCR-induced transactivation of CXCR4 and TCR–CXCR4 complex
  formation required for PI3Kγ/PREX1 signaling and robust T cell cytokine secretion.
  Our proposed model is that TCR/CD3 stimulation results in the activation of GRK2
  through Tyr phosphorylation by an Src kinase. GRK2 then transactivates CXCR4 by
  phosphorylation of CXCR4–Ser-339, which drives TCR–CXCR4 complex formation. TCR–CXCR4
  complexes induce PREX1 localization to the plasma membrane via a mechanism requiring
  PI3Kγ. Activation of the PREX1-signaling pathway downstream of the TCR–CXCR4 complex
  results in mRNA stabilization and thus robust IL-2 and IL-10 production.
papertitle: GRK2 mediates TCR-induced transactivation of CXCR4 and TCR–CXCR4 complex
  formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretion.
reftext: Brittney A. Dinkel, et al. J Biol Chem. 2018 Sep 7;293(36):14022-14039.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9571774
figid_alias: PMC6130939__F11
figtype: Figure
redirect_from: /figures/PMC6130939__F11
ndex: 1789aaa7-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6130939__zbc0371892730011.html
  '@type': Dataset
  description: GRK2 mediates TCR-induced transactivation of CXCR4 and TCR–CXCR4 complex
    formation required for PI3Kγ/PREX1 signaling and robust T cell cytokine secretion.
    Our proposed model is that TCR/CD3 stimulation results in the activation of GRK2
    through Tyr phosphorylation by an Src kinase. GRK2 then transactivates CXCR4 by
    phosphorylation of CXCR4–Ser-339, which drives TCR–CXCR4 complex formation. TCR–CXCR4
    complexes induce PREX1 localization to the plasma membrane via a mechanism requiring
    PI3Kγ. Activation of the PREX1-signaling pathway downstream of the TCR–CXCR4 complex
    results in mRNA stabilization and thus robust IL-2 and IL-10 production.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - TRAV29DV5
  - TRAJ60
  - TRAC
  - ASS1
  - CXCR4
  - SRC
  - FGR
  - FYN
  - YES1
  - PREX1
  - ZAP70
  - GRK2
  - NPY6R
  - IL2
  - IL10
  - tradv29.0
  - tradv28.0
  - tradv27.0
  - tradv25.0.4
  - tradv24.0.5
  - tradv25.0.3
  - tradv24.0.4
  - tradv41.0
  - tradv40.0
  - tradv36.2.12
  - tradv23.3.8
  - si:busm1-40g1.9
  - si:busm1-18f12.1
  - si:busm1-18f12.2
  - si:busm1-18f12.3
  - si:busm1-18f12.4
  - si:busm1-18f12.5
  - si:busm1-18f12.6
  - si:busm1-18f12.7
  - si:busm1-18f12.8
  - si:busm1-18f12.9
  - si:busm1-1c23.10
  - tradv25.0.2
  - tradv24.0.3
  - tradv26.0
  - tradv25.0.1
  - tradv24.0.2
  - tradv23.1.3
  - tradv24.0.1
  - tradv23.1.2
  - tradv23.1.1
  - tradv22.0
  - tradv21.0
  - tradv20.0
  - tradv19.0
  - tradv18.0
  - tradv17.0
  - tradv16.0
  - tradv15.0
  - tradv14.0
  - si:busm1-40g1.10
  - si:busm1-40g1.11
  - si:busm1-40g1.12
  - si:busm1-40g1.13
  - si:busm1-40g1.14
  - si:busm1-40g1.15
  - si:busm1-40g1.16
  - si:busm1-40g1.17
  - si:busm1-40g1.18
  - si:busm1-40g1.19
  - si:busm1-40g1.20
  - si:busm1-40g1.21
  - si:busm1-40g1.22
  - si:busm1-40g1.23
  - si:busm1-40g1.25
  - si:busm1-40g1.26
  - si:busm1-40g1.30
  - si:busm1-40g1.31
  - si:busm1-40g1.32
  - si:busm1-40g1.34
  - si:busm1-40g1.36
  - si:busm1-40g1.37
  - si:busm1-40g1.38
  - si:busm1-40g1.39
  - si:busm1-101l20.1
  - si:busm1-101l20.2
  - si:busm1-101l20.3
  - si:busm1-101l20.4
  - si:busm1-101l20.5
  - si:busm1-101l20.6
  - si:busm1-101l20.7
  - si:busm1-101l20.8
  - si:busm1-101l20.9
  - si:busm1-172d23.7
  - si:busm1-172d23.9
  - si:busm1-18f12.10
  - si:busm1-18f12.12
  - si:busm1-18f12.13
  - si:busm1-18f12.14
  - si:busm1-18f12.15
  - si:busm1-18f12.16
  - si:busm1-18f12.17
  - si:busm1-18f12.18
  - si:busm1-18f12.19p
  - si:busm1-18f12.20
  - si:busm1-18f12.21
  - si:busm1-18f12.22
  - si:busm1-18f12.23
  - si:busm1-18f12.24
  - si:busm1-18f12.25
  - si:busm1-18f12.26
  - si:busm1-18f12.27
  - si:busm1-18f12.28
  - si:busm1-18f12.29
  - si:busm1-18f12.30
  - si:busm1-18f12.31
  - si:busm1-18f12.32
  - si:busm1-18f12.33
  - tradv23.1.4
  - tradv31.0
  - si:busm1-18f12.36
  - si:busm1-101l20.10
  - si:busm1-101l20.27
  - si:busm1-138m20.11
  - si:busm1-138m20.24
  - si:busm1-138m20.25
  - si:busm1-138m20.26
  - si:busm1-138m20.27
  - si:busm1-138m20.28
  - si:busm1-138m20.30
  - si:busm1-138m20.31
  - si:busm1-138m20.32
  - si:busm1-138m20.33
  - si:busm1-138m20.34
  - si:busm1-138m20.35
  - si:busm1-138m20.36
  - si:busm1-138m20.37
  - si:busm1-172d23.10
  - si:busm1-172d23.11
  - tradv7.0
  - tradv6.0.1
  - tradv5.0.1
  - tradv2.0.3
  - tradv3.0.4
  - si:busm1-172d23.17
  - si:busm1-172d23.18
  - si:busm1-172d23.19
  - si:busm1-172d23.21
  - si:busm1-172d23.22
  - tradv2.0.1
  - tradv1
  - trac
  - traj111
  - traj110
  - traj107
  - traj105
  - si:busm1-172d23.32
  - traj98
  - traj97
  - traj96
  - traj95
  - traj93
  - traj91
  - traj90
  - traj101
  - si:busm1-172d23.42
  - ass1
  - cxcr4b
  - src
  - prex1
  - pak2a
  - itpka
  - zap70
  - parapinopsinb
  - il10
  - Tcr
  - Ass
  - Src42A
  - Csk
  - Src64B
  - br
  - mts
  - Cds
  - cd-s
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - TCR
  - Tyr
  - Ser
  - IPI
  - Paroxetine
  - Piceatannol
---
